• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

浮游和固着状态的克菲假丝酵母临床分离株的体外抗真菌药敏模式

In vitro antifungal susceptibility patterns of planktonic and sessile Candida kefyr clinical isolates.

作者信息

Nagy Fruzsina, Bozó Aliz, Tóth Zoltán, Daróczi Lajos, Majoros László, Kovács Renátó

机构信息

Department of Medical Microbiology, Faculty of Medicine, University of Debrecen, Hungary.

Department of Solid State Physics, Faculty of Science and Technology, University of Debrecen, Hungary.

出版信息

Med Mycol. 2018 Jun 1;56(4):493-500. doi: 10.1093/mmy/myx062.

DOI:10.1093/mmy/myx062
PMID:28992253
Abstract

The activity of fluconazole, amphotericin B, caspofungin and micafungin was determined using XTT-based fungal damage assays against planktonic cells, early and mature biofilms of Candida kefyr. Median MICs of planktonic cells were 0.25 mg/l, 0.25 mg/l, 0.5 mg/l, and 0.06 mg/l for fluconazole, amphotericin B, caspofungin, and micafungin, respectively. Fluconazole showed at least 50% fungal damage at ≥4 mg/l (51.5% ± 6.63% to 78.38% ± 1.44%) and at ≥128 mg/l (57.88% ± 9.2% to 67.25% ± 9.59%), while amphotericin B produced an even higher anti-biofilm effect at ≥0.5 mg/l (64.63% ± 6.79% to 79.5% ± 5.9%) and at ≥0.12 mg/l (77.63% ± 8.43% to 92.75% ± 1.89%) against early and mature biofilms, respectively. In case of micafungin, 50% fungal damage was observed at ≥0.06 mg/l (66.88% ± 10.16% to 98.63% ± 1.24%) and ≥0.25 mg/l (74.13% ± 10.77% to 99.38% ± 0.38%) for early and mature biofilms, respectively. Caspofungin-exposed cells showed an unexpected susceptibility pattern, that is, planktonic cells showed significantly decreased susceptibility at concentrations ranging from 0.015 mg/l to 1 mg/l compared to biofilms (P < .05-.01). The damage in planktonic cells and biofilms was comparable at higher concentrations. For planktonic cells and biofilms, 50% fungal damage was observed first at 0.5 mg/l (59.75% ± 3.16%) and at 0.06 mg/l (70.25% ± 10.95%), respectively. This unexpected pattern was confirmed using scanning electron microscopy. The unusual susceptibility pattern observed at lower caspofungin concentrations may explain the poorer outcome of caspofungin-treated C. kefyr infections documented in certain patient populations. As this phenomenon was markedly less apparent in case of micafungin, these data suggest that micafungin may be a more reliable option than caspofungin for the treatment of C. kefyr infections.

摘要

采用基于XTT的真菌损伤试验,测定了氟康唑、两性霉素B、卡泊芬净和米卡芬净对解脂耶氏酵母浮游细胞、早期和成熟生物被膜的活性。氟康唑、两性霉素B、卡泊芬净和米卡芬净对浮游细胞的MIC50分别为0.25mg/l、0.25mg/l、0.5mg/l和0.06mg/l。氟康唑在≥4mg/l(51.5%±6.63%至78.38%±1.44%)和≥128mg/l(57.88%±9.2%至67.25%±9.59%)时显示至少50%的真菌损伤,而两性霉素B在≥0.5mg/l(64.63%±6.79%至79.5%±5.9%)和≥0.12mg/l(77.63%±8.43%至92.75%±1.89%)时分别对早期和成熟生物被膜产生更高的抗生物被膜效果。对于米卡芬净,在≥0.06mg/l(66.88%±10.16%至98.63%±1.24%)和≥0.25mg/l(74.13%±10.77%至99.38%±0.38%)时分别观察到早期和成熟生物被膜有50%的真菌损伤。卡泊芬净处理的细胞呈现出意外的敏感性模式,即与生物被膜相比,浮游细胞在0.015mg/l至1mg/l浓度范围内敏感性显著降低(P<0.05 - 0.01)。在较高浓度下,浮游细胞和生物被膜的损伤相当。对于浮游细胞和生物被膜,分别在0.5mg/l(59.75%±3.16%)和0.06mg/l(70.25%±10.95%)时首次观察到50%的真菌损伤。使用扫描电子显微镜证实了这种意外模式。在较低卡泊芬净浓度下观察到的异常敏感性模式可能解释了在某些患者群体中卡泊芬净治疗解脂耶氏酵母感染效果较差。由于这种现象在米卡芬净的情况下明显不那么明显,这些数据表明米卡芬净可能是比卡泊芬净更可靠的治疗解脂耶氏酵母感染的选择。

相似文献

1
In vitro antifungal susceptibility patterns of planktonic and sessile Candida kefyr clinical isolates.浮游和固着状态的克菲假丝酵母临床分离株的体外抗真菌药敏模式
Med Mycol. 2018 Jun 1;56(4):493-500. doi: 10.1093/mmy/myx062.
2
Activities of nine antifungal agents against Candida auris biofilms.九种抗真菌药物对耳念珠菌生物膜的活性。
Mycoses. 2021 Apr;64(4):381-384. doi: 10.1111/myc.13223. Epub 2020 Dec 13.
3
Candida and candidaemia. Susceptibility and epidemiology.念珠菌与念珠菌血症。药敏性与流行病学。
Dan Med J. 2013 Nov;60(11):B4698.
4
The novel oral glucan synthase inhibitor SCY-078 shows in vitro activity against sessile and planktonic Candida spp.新型口服葡聚糖合成酶抑制剂 SCY-078 对念珠菌属的浮游和黏附状态均具有体外活性。
J Antimicrob Chemother. 2017 Jul 1;72(7):1969-1976. doi: 10.1093/jac/dkx010.
5
Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosis biofilms.卡泊芬净和米卡芬净联合法尼醇对近平滑念珠菌生物膜的影响。
Int J Antimicrob Agents. 2016 Apr;47(4):304-10. doi: 10.1016/j.ijantimicag.2016.01.007. Epub 2016 Feb 17.
6
Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins.念珠菌生物膜的抗真菌药敏性:两性霉素B脂质制剂和棘白菌素的独特疗效
Antimicrob Agents Chemother. 2002 Jun;46(6):1773-80. doi: 10.1128/AAC.46.6.1773-1780.2002.
7
Biofilms of Candida spp. from the ocular conjunctiva of horses with reduced azole susceptibility: a complicating factor for the treatment of keratomycosis?来自马眼结膜的唑类敏感性降低的念珠菌属生物膜:角膜真菌病治疗的一个复杂因素?
Vet Ophthalmol. 2017 Nov;20(6):539-546. doi: 10.1111/vop.12465. Epub 2017 Apr 18.
8
In vitro activity of antifungal combinations against Candida albicans biofilms.抗真菌药物联合应用对白色念珠菌生物膜的体外活性研究
J Antimicrob Chemother. 2010 Feb;65(2):271-4. doi: 10.1093/jac/dkp429. Epub 2009 Dec 8.
9
The In Vitro Activity of Fluconazole, Amphotericin B and Echinocandins Against Cyberlindnera fabianii Planktonic Cells and Biofilms.氟康唑、两性霉素 B 和棘白菌素类对浮游细胞和生物膜的体外活性。
Mycopathologia. 2023 Apr;188(1-2):111-118. doi: 10.1007/s11046-022-00688-9. Epub 2022 Nov 18.
10
In vitro activity of antifungal combinations against planktonic and sessile cells of Candida albicans isolated from medical devices in an intensive care department.在重症监护病房医疗器械分离的白色念珠菌浮游细胞和生物被膜细胞的抗真菌药物联合药敏试验。
J Mycol Med. 2018 Sep;28(3):414-418. doi: 10.1016/j.mycmed.2018.06.008. Epub 2018 Jul 19.

引用本文的文献

1
In vitro analysis of postbiotic antimicrobial activity against Candida Species in a minimal synthetic model simulating the gut mycobiota in obesity.体外分析在肥胖人群肠道共生菌模拟最小合成模型中对念珠菌属的后生元抗菌活性。
Sci Rep. 2024 Jul 21;14(1):16760. doi: 10.1038/s41598-024-66806-3.
2
Comparative analysis of enzymatic profiles and biofilm formation in clinical and environmental Candida kefyr isolates.临床和环境来源的近平滑假丝酵母分离株的酶谱和生物膜形成的比较分析。
Environ Microbiol Rep. 2024 Jun;16(3):e13282. doi: 10.1111/1758-2229.13282.
3
The In Vitro Activity of Fluconazole, Amphotericin B and Echinocandins Against Cyberlindnera fabianii Planktonic Cells and Biofilms.
氟康唑、两性霉素 B 和棘白菌素类对浮游细胞和生物膜的体外活性。
Mycopathologia. 2023 Apr;188(1-2):111-118. doi: 10.1007/s11046-022-00688-9. Epub 2022 Nov 18.
4
Overview on the Infections Related to Rare Species.稀有物种相关感染概述
Pathogens. 2022 Aug 24;11(9):963. doi: 10.3390/pathogens11090963.
5
Invasive Candida kefyr infection presenting as pyelonephritis in an ICU hospitalized COVID-19 patient: Case report and review of the literature.ICU 住院 COVID-19 患者中以肾盂肾炎为表现的侵袭性恺木假丝酵母菌感染:病例报告及文献复习。
J Mycol Med. 2022 May;32(2):101236. doi: 10.1016/j.mycmed.2021.101236. Epub 2021 Dec 23.
6
First case of () late onset keratitis after lamellar endothelial corneal graft.板层内皮角膜移植术后迟发性角膜炎首例()
Med Mycol Case Rep. 2021 Feb 12;32:21-24. doi: 10.1016/j.mmcr.2021.02.001. eCollection 2021 Jun.
7
Synergistic Antifungal Activity of Chitosan with Fluconazole against , , and Fluconazole-Resistant Strains.壳聚糖与氟康唑联合抗 、 、 和氟康唑耐药菌株的协同抗真菌活性。
Molecules. 2020 Nov 3;25(21):5114. doi: 10.3390/molecules25215114.
8
Scientific Opinion on the update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA (2017-2019).关于向欧洲食品安全局通报的(2017 - 2019年)有意添加到食品或饲料中的QPS推荐生物制剂清单更新的科学意见。
EFSA J. 2020 Feb 3;18(2):e05966. doi: 10.2903/j.efsa.2020.5966. eCollection 2020 Feb.
9
Update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA 10: Suitability of taxonomic units notified to EFSA until March 2019.向欧洲食品安全局通报的有意添加到食品或饲料中的QPS推荐生物制剂清单更新10:截至2019年3月向欧洲食品安全局通报的分类单元的适用性。
EFSA J. 2019 Jul 15;17(7):e05753. doi: 10.2903/j.efsa.2019.5753. eCollection 2019 Jul.